Background/Aims: The molecular mechanisms contributing to the tumorigenesis
of insulinomas are poorly understood. Disruption of the cell cycle due to
inactivation of the p16(INK4a) tumor-suppressor gene was identified in a va
riety of human tumors, including gastrinomas and nonfunctioning endocrine p
ancreatic carcinomas. In this study the role of p16(INK4a) i, the tumorigen
esis of insulinomas was evaluated. Merhods: Seventeen insulinomas (14 benig
n, 3 malignant) were analyzed for genetic alterations in the p16(INK4a) tum
or-suppressor gene by SSCP, PCR-based deletion and methylation-specific ass
ays, p16 expression was determined by immunohistochemistry. Results: One ma
lignant insulinoma showed a homozygous deletion of p16(INK4a) and another t
wo benign insulinomas revealed aberrant methylation of the p16(INK4a) promo
ter region. All three tumors lacked p16 expression according to immunohisto
chemistry. None of the insulinomas carried intragenic p16(INK4a) mutations.
In total, 17% of insulinomas had p16(INK4a) alterations. Conclusions: The
p16(INK4a) tumor-suppressor gene contributes to tumorigenesis in only a sma
ll subset of insulinomas. Copyright (C) 2000 S. Karger AG. Basel.